Newpath is a private venture capital investment fund focused on disruptive treatments and technologies in the life science space. We search for innovative approaches across diverse fields including but not limited to: pharmaceuticals, regenerative and personalized medicine, basic sciences, devices, drug discovery, cellular and gene therapies, robotics, AR/VR and AI. With each investment, Newpath seeks to optimize performance by aligning the interests of academic founders, management teams, and investor groups.
View Top Employees from Newpath PartnersWebsite | https://www.newpath.partners/ |
Revenue | $3 million |
Employees | 7 (3 on RocketReach) |
Founded | 2018 |
Address | 800 Boylston Street Suite 2222, Boston, Massachusetts 02199, US |
Phone | (978) 771-9999 |
Industry | Venture Capital and Private Equity Principals, Finance General, Finance |
Competitors | Cedar Springs Capital, Cross Creek, Intersouth Partners, Saints Capital, 盛景网联科技股份有限公司 |
SIC | SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 523 Companies, NAICS Code 5239 Companies, NAICS Code 52 Companies |
Looking for a particular Newpath Partners employee's phone or email?
The Newpath Partners annual revenue was $3 million in 2024.
3 people are employed at Newpath Partners.
Newpath Partners is based in Boston, Massachusetts.
The NAICS codes for Newpath Partners are [523, 5239, 52].
The SIC codes for Newpath Partners are [679, 67].